125 related articles for article (PubMed ID: 9838470)
1. Beneficial effect of ursodeoxycholic acid on serum gamma-GTP in patients with biliary atresia following living related liver transplantation.
Tanaka H; Kita Y; Kawarasaki H; Harihara Y; Ito M; Mizuta K; Terawaki K; Nakahara S; Hashizume K; Makuuchi M
Transplant Proc; 1998 Nov; 30(7):3326-7. PubMed ID: 9838470
[No Abstract] [Full Text] [Related]
2. Ursodeoxycholic acid as a supplementary treatment in corrected biliary atresia.
Smaropoulos EC; Kaselas B
Eur J Pediatr Surg; 2006 Apr; 16(2):138-9. PubMed ID: 16685625
[No Abstract] [Full Text] [Related]
3. Ursodeoxycholic acid in serum and liver tissue in patients with end-stage cholestatic liver cirrhosis.
Kita Y; Sakakura H; Hirata M; Harihara Y; Tanaka H; Ito M; Yoshino H; Takayama T; Kubota K; Hashizume K; Makuuchi M
Transplant Proc; 1999 Nov; 31(7):2897-8. PubMed ID: 10578330
[No Abstract] [Full Text] [Related]
4. Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis.
Ohba K; Omagari K; Kusakari C; Kadokawa Y; Hayashida K; Takeshima F; Mizuta Y; Murata I; Nakanuma Y; Kohno S
Dig Dis Sci; 2005 Jan; 50(1):201-6. PubMed ID: 15712661
[No Abstract] [Full Text] [Related]
5. Delayed postnatal presentation of biliary atresia in 2 premature neonates.
Mourier O; Franchi-Abella S; Ackermann O; Branchereau S; Gonzales E; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):489-91. PubMed ID: 21407106
[No Abstract] [Full Text] [Related]
6. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia.
Meyers RL; Book LS; O'Gorman MA; Jackson WD; Black RE; Johnson DG; Matlak ME
J Pediatr Surg; 2003 Mar; 38(3):406-11. PubMed ID: 12632357
[TBL] [Abstract][Full Text] [Related]
7. Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia.
Kotb MA
J Pediatr Surg; 2008 Jul; 43(7):1321-7. PubMed ID: 18639689
[TBL] [Abstract][Full Text] [Related]
8. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia.
Willot S; Uhlen S; Michaud L; Briand G; Bonnevalle M; Sfeir R; Gottrand F
Pediatrics; 2008 Dec; 122(6):e1236-41. PubMed ID: 19029197
[TBL] [Abstract][Full Text] [Related]
9. Jeune syndrome and liver disease: report of three cases treated with ursodeoxycholic acid.
Labrune P; Fabre M; Trioche P; Estournet-Mathiaud B; Grangeponte MC; Rambaud C; Maurage C; Bernard O
Am J Med Genet; 1999 Dec; 87(4):324-8. PubMed ID: 10588838
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
11. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
[TBL] [Abstract][Full Text] [Related]
12. Effects of the herbal medicine Inchinko-to on liver function in postoperative patients with biliary atresia--a pilot study.
Iinuma Y; Kubota M; Yagi M; Kanada S; Yamazaki S; Kinoshita Y
J Pediatr Surg; 2003 Nov; 38(11):1607-11. PubMed ID: 14614709
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cholestatic liver disease].
Pleşa A
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
[TBL] [Abstract][Full Text] [Related]
14. A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.
Santos VN; Lanzoni VP; Szejnfeld J; Shigueoka D; Parise ER
Braz J Med Biol Res; 2003 Jun; 36(6):723-9. PubMed ID: 12792701
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of primary biliary cholangitis in a "teen" male patient.
Muratori P; Lenzi M; Muratori L
Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):e20-e21. PubMed ID: 30145280
[No Abstract] [Full Text] [Related]
16. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.
Leuschner M; Dietrich CF; You T; Seidl C; Raedle J; Herrmann G; Ackermann H; Leuschner U
Gut; 2000 Jan; 46(1):121-6. PubMed ID: 10601067
[TBL] [Abstract][Full Text] [Related]
17. [Correction of metabolic disturbances in patients with cholestasis].
Rodonezhskaia EV; Kharchenko NV
Lik Sprava; 2001; (3):148-9. PubMed ID: 11560006
[TBL] [Abstract][Full Text] [Related]
18. Transient hyperphosphatasemia after liver transplantation in infancy.
Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
[No Abstract] [Full Text] [Related]
19. [No complaints, but constantly elevated cholestatic serum liver tests].
Kherbèche H
Praxis (Bern 1994); 2011 Jul; 100(14):865-7. PubMed ID: 21732301
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
Transpl Int; 1992; 5 Suppl 1():S187-9. PubMed ID: 14621771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
